Linda C. Hogan, Head, Business Development and Strategy at CoLucid Pharmaceuticals, Inc. (CLCD), sold 3,657 shares at $36.25 ($128K) on 2017-01-03, disclosed to the SEC on 2017-01-05.
Open-market sale of $128k CLCD by Head, Business Development and Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.25 | 718 | $26K | 20.3% |
| 2 | $36.40 | 185 | $7K | 5.3% |
| 3 | $33.55 | 477 | $16K | 12.5% |
| 4 | $33.55 | 477 | $16K | 12.5% |
| 5 | $34.40 | 600 | $21K | 16.1% |
| 6 | $35.61 | 600 |
| $21K |
| 16.7% |
| 7 | $35.61 | 600 | $21K | 16.7% |
| Total | $35.04 avg | 3,657 | $128K | 100% |
| Filing → |
| CLCD | SELL | 2016-11-01 | $22K | — | Filing → |
| CLCD | SELL | 2016-10-05 | $96K | — | Filing → |
| CLCD | SELL | 2016-09-07 | $969K | — | Filing → |